amol athawale people page on Anadi Algo News

Friday, May 1, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
People Landing|12 matching stories

amol athawale News, Mentions & Market Context

AI-analyzed market coverage and mentions for amol athawale, including related stories and trading context.

What Traders Do Next

amol athawale is more useful with a process around it.

Use these pages to understand the story first. Execution usually comes later, after the idea is filtered, tested, and sized correctly.

This is here if you want to go deeper, not as a push.Explore Anadi
Look for entry points near support levels for TVSMOTOR and LODHA, targeting specified upside.|Quick check: TVSMOTOR bearish bias (oversold), LODHA bullish bias (+3.1% 1d).

Latest amol athawale Mentions

Maintain a cautious stance on pharma stocks with significant US exposure, especially those with recent regulatory issues; look for companies with strong compliance records and diversified revenue streams.|Quick check: GRANULES bullish bias (-1.5% 1d), SUNPHARMA bearish bias (+0.1% 1d).
For JSW Steel, monitor global steel prices and domestic demand cues; for TVS Motor, track auto sales data and festive season demand. Maintain strict stop-losses given the short-term nature of the recommendations.|Quick check: JSWSTEEL neutral (+2.1% 1d), TVSMOTOR neutral (+1.9% 1d).
For drug discovery companies, focus on pipeline milestones, clinical trial results, and funding rounds; these are high-beta plays with significant upside potential but also high failure rates.|Quick check: SUVEN neutral, SUVENPHAR neutral.
Bullish on recommended stocks for short-term; use provided targets and stop-losses.|Quick check: VEDL neutral (+2.6% 1d), CANBK neutral (+2.3% 1d).
Bearish bias on API and bulk drug manufacturers; cautious on integrated pharma companies due to potential margin pressure.|Quick check: SUNPHARMA neutral (+0.3% 1d), CIPLA bearish bias (oversold).
Bullish for recommended stocks; look for entry points based on technical analysis.|Quick check: TITAN neutral (+1.2% 1d), GMRINFRA neutral.
Short-term bearish bias for the pharma sector; monitor news on propane supply and company-specific disclosures regarding production impact.|Quick check: SUNPHARMA neutral (-1.4% 1d), CIPLA bearish bias (-1.4% 1d).
For auto stocks, monitor volume growth and demand mix; consider short-term trades on specific recommendations like Hyundai, but be mindful of broader sector weakness.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (-2.4% 1d).